Sanofi Pasteur

Influenza Prevention in Older Adults

Clinical research in influenza vaccination focuses on older adults, with interest in quadrivalent influenza vaccines and protection against influenza-related hospitalisation and pneumonia. The work reflects a clear emphasis on age-related respiratory infection prevention.

  • Older adult immunisation
  • Quadrivalent influenza vaccine
  • Influenza-related hospitalisation
  • Pneumonia prevention

These studies are centred on improving protection against seasonal respiratory disease in ageing populations.

Meningococcal Disease and Conjugate Vaccines

Research activity includes meningococcal infection and meningococcal ACYW conjugate vaccines, with attention to immune responses against serogroups A, C, W, and Y. The sponsor’s portfolio covers both primary immunisation and booster vaccination across childhood and adolescence.

  • MenACYW conjugate vaccine
  • Meningococcal serogroups A, C, W, and Y
  • Booster immunisation
  • Paediatric and adolescent vaccination

Interest extends to durable immune protection after earlier childhood vaccination and later revaccination.

Yellow Fever Vaccination

Clinical studies also address yellow fever prevention through investigation of an investigational yellow fever vaccine in adults. The research is directed toward maintaining vaccine-induced protection against this mosquito-borne viral infection.

  • Yellow fever immunisation
  • Investigational vaccine
  • Adult vaccination
  • Viral infection prevention

This area reflects ongoing interest in travel and endemic-disease vaccination.

Healthy Volunteers in Vaccine Immunogenicity Research

Some studies involve healthy volunteers to assess antibody response, seroconversion, and immune persistence after vaccination. This supports evaluation of how well vaccines stimulate and maintain protective immunity in populations without active disease.

  • Healthy volunteer studies
  • Antibody response
  • Seroconversion
  • Immune persistence

The research spans multiple age groups, including infants, toddlers, children, adolescents, adults, and older adults.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study Comparing the Safety and Immune Response of the Investigational vYF Vaccine and Stamaril for Yellow Fever in Adults in Europe and Asia

    Not recruiting

    1 1 1
    Investigated diseases:
    Finland France Germany Spain
  • Study on the Safety and Immune Response of a Booster Dose of MenACYW Conjugate Vaccine in Children and Adolescents Previously Vaccinated for Meningococcal Infection

    Not recruiting

    1 1 1 1
    Finland Germany Hungary Spain
  • Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Denmark
  • Study on the Safety and Immune Response of MenACYW Conjugate Vaccine Compared to a Drug Combination in Healthy Infants and Toddlers

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Czechia Denmark Finland Germany Poland Romania